$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter


Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions' earnings, with the highest sales estimate coming in at $179.71 million and the lowest estimate coming in at $171.10 million.



from Biotech News